UMIN-ICDS Clinical Trial

Unique ID issued by UMIN UMIN000050777
Receipt number R000057836
Scientific Title Appetite and subjective symptoms in patients after hematopoietic stem cell transplantation: Cross-sectional study
Date of disclosure of the study information 2023/04/17
Last modified on 2024/04/05 12:35:02

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Appetite and subjective symptoms in patients after hematopoietic stem cell transplantation: Cross-sectional study

Acronym

Appetite and subjective symptoms in patients after hematopoietic stem cell transplantation: Cross-sectional study

Scientific Title

Appetite and subjective symptoms in patients after hematopoietic stem cell transplantation: Cross-sectional study

Scientific Title:Acronym

Appetite and subjective symptoms in patients after hematopoietic stem cell transplantation:Cross-sectional study

Region

Japan


Condition

Condition

Hematopoietic tumor

Classification by specialty

Hematology and clinical oncology Nursing

Classification by malignancy

Malignancy

Genomic information

NO


Objectives

Narrative objectives1

To determine the severity of appetite and subjective symptoms in outpatients after hematopoietic stem cell transplantation.

Basic objectives2

Others

Basic objectives -Others

To determine the characteristics associated with appetite in outpatients after hematopoietic stem cell transplantation.

Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Appetite

Key secondary outcomes

subjective symptoms, nutritional data


Base

Study type

Observational


Study design

Basic design


Randomization


Randomization unit


Blinding


Control


Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms


Purpose of intervention


Type of intervention


Interventions/Control_1


Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

18 years-old <=

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

1.Patients who diagnosed hematopoietic tumor and after autologous and allogeneic hematopoietic stem cell transplantation
2.Outpatients who have been discharged from hospital for at least one month
3.18 years of age or older

Key exclusion criteria

1.Patients who have severe mental illness
2.Patients who have been diagnosed with relapse

Target sample size

80


Research contact person

Name of lead principal investigator

1st name Kaori
Middle name
Last name Yagasaki

Organization

Keio University

Division name

Faculty of nursing and medical care

Zip code

160-0016

Address

35 Shinanomachi, Shinjuku-ku, Tokyo

TEL

03-5363-2157

Email

yagasaki@sfc.keio.ac.jp


Public contact

Name of contact person

1st name Maho
Middle name
Last name Inoue

Organization

Keio University Graduate School

Division name

Graduate School of Health Management, Nursing

Zip code

252-0816

Address

4411 Endo, Fujisawa-shi, Kanagawa

TEL

0466-49-6200

Homepage URL


Email

h22702mi@sfc.keio.ac.jp


Sponsor or person

Institute

Keio University

Institute

Department

Personal name



Funding Source

Organization

None

Organization

Division

Category of Funding Organization

Self funding

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Keio University School of Medicine Ethics Committee

Address

35 Shinanomachi, Shinjuku-ku, Tokyo

Tel

03-5363-3503

Email

med-rinri-jimu@adst.keio.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions

慶應義塾大学病院(東京都)


Other administrative information

Date of disclosure of the study information

2023 Year 04 Month 17 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled

55

Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2023 Year 02 Month 07 Day

Date of IRB

2023 Year 03 Month 28 Day

Anticipated trial start date

2023 Year 04 Month 17 Day

Last follow-up date

2025 Year 12 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information

Observational cross-sectional study


Management information

Registered date

2023 Year 04 Month 06 Day

Last modified on

2024 Year 04 Month 05 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/icdr_e/ctr_view.cgi?recptno=R000057836


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name